chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Altered sense of taste. I started noticing a faint minty taste in my mouth around 3 days after receiving my booster shot. The taste does not go away, and has altered my sense of taste. My sense of smell seems unchanged.  It has been 17 days since my injection, and I am still experiencing this symptom. I do not know if it was caused by the vaccine or is a coincidence.
Looked over patient's consent form and saw that the patient had multiple allergies such as Keflex, Amoxicillin, and Bactrim. And everything else did not prevent her from getting the vaccine.  Pt did not mark that she had any health issues on the consent form.  Prepped the vaccines and called both husband and the patient into the room to get their shots. Verified both patients date of birth and confirmed that they were getting the JJ vaccines.  Gave the husband the first shot and went over the side effects of the JJ and the rare occurrences of GBS in men.  Gave him the shot and we discussed the differences of the vaccine and why they were getting the vaccine because at their son's school nobody was masked and up in each other's faces and they wanted to get vaccinated.  The husband said that a few doctors told him that the Moderna and Pfizer did not stay in one place and how the JJ does and it is like the flu shot.  Then the patient got into the chair and went over the side effects and how it effects women about risk of clotting and it affects women that are smokers and on birth control. The patient confirmed that she's good and that everything will be fine.  I discussed her allergies and that bc of that we ask that all patient stay and be observed for at least 30 minutes.  And then gave the shot to the patient and everything seemed fine.  Then the husband and I continued our discussion about how they developed the Moderna and the Pfizer vaccines and then the patient said that her heart was racing and how she was feeling dizzy.  I advised the patient to stay down and sit and asked her husband to look over her and I grabbed her a cup of orange juice and rice krispy treat and she ate it and drank the orange juice and she said that she was feeling a little better, but then progressively looked worse. Staff continued to watch over her as they took her blood pressure and pulse ox and the first blood pressure reading was 144/89 and 81 pulse, then a second blood pressure reading was 151/90 and her pulse ox was 99% but she was trying to breathe in and out slowly.  At that time 20 minutes had passed and I had to go to lunch and other staff members were looking over her. Staff member brought up POTS syndrome but the consent form didn't indicate any about dizziness or fainting or health condition for before and after shots.  Staff member and I went over shot technique and everything was fine in our eyes.   Patient experienced dizziness, rapid breathing, and chest pain
inj site became swollen, tender the following day devel rash @ inj site, rash spreading 2 days later tx was to use warm compress & massage;take DPH;
Patient received injection on 9/24/15. She came to the pharmacy on 10-6-15 with hives and redness at site of injection approximately 3 inch/2 inch.  Complained of dizziness, diarrhea which I told her is probably unrelated.
Started 6/23/03 11:30 PM extreme pain - throbbing, unable to move finger. Site red, blotchy. Pain location right shoulder to above right elbow. 6/26/03 Warm to touch, blotchy. Tylenol 2-3 per day.
receive vaccine at 12:20pm.  At 12:27 patient felt his throat beginning to swell and throat was "really scratchy".  After drinking some water patient stated his throat felt better.  at 12:45 patient stated his symptoms were mostly gone.  At 1:15 patient was allowed to go home after 30 minutes of no symptoms with recommendation that if symptoms returned to go immediately to the ER
This case was reported by a physician via call center representative and described the occurrence of injection site erythema in approximately 5 adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced injection site erythema and injection site warmth. On an unknown date, the outcome of the injection site erythema and injection site warmth were unknown. It was unknown if the reporter considered the injection site erythema and injection site warmth to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The physician reported that she had seen approximately 5 patients reporting heat and redness at the injection site following the 1st dose of SHINGRIX. The SHINGRIX vaccine had been administered at several local pharmacies. The reporting physician did not keep a log of patient information and had no access to product details. The patients reported symptoms to the doctor over the last few months. It was possible but not verifiable that these patients had previously been reported.
Patient became itchy after about ten minutes, then after about 35 minutes was complaining of shortness of breath
Presented with CP/headache; + Covid; EKG with suspected viral pericarditis; No PNA; tx with supportive care, no antibiotics; Tx: Vit C, Vit D3, Lovenox, hydroxychloroquine, singulair, zinc, prednisone; minimal supplemenat O2 during stay; on room air at d/c
Patient was admitted to the hospital on 04/15/2021. He was in the ICU and on a ventilator for majority of the time.
similar to going into shock; pain in my jaw area; diagnosed with Trigeminal Neuralgia (type 2); This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 03Mar2021 11:00 (Lot number: EN6205) at the age of 61 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing); "cholesterol" (unspecified if ongoing); "Known allergies: Many antibiotics" (unspecified if ongoing); "covid" (unspecified if ongoing), notes: If covid prior vaccination: Yes. The patient did not receive any vaccines within four weeks prior to the vaccination. Prior to vaccination patient was diagnosed with COVID-19. Since the vaccination the patient had been tested for COVID-19. Concomitant medication(s) included: METOPROLOL; AMLODIPINE; XANAX; LOSARTAN; MOTRIN [IBUPROFEN]. Past drug history included: Rphine, reaction(s): "known allergies: rphine".  The following information was reported: SHOCK (disability, medically significant) with onset 07Apr2021, outcome "not recovered", described as "similar to going into shock"; PAIN IN JAW (disability) with onset 07Apr2021, outcome "not recovered", described as "pain in my jaw area"; TRIGEMINAL NEURALGIA (disability) with onset 07Apr2021, outcome "not recovered", described as "diagnosed with Trigeminal Neuralgia (type 2)". Patient began having pain in her jaw area within one month of injection. Reaction to vaccine: similar to going into shock for 4 days. Have been diagnosed with Trigeminal Neuralgia (type 2). Have it ever had any signs of TN prior to vaccination. The events "similar to going into shock", "pain in my jaw area" and "diagnosed with trigeminal neuralgia (type 2)" were evaluated at the physician office visit. Disability or permanent damage. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (06Oct2021) negative, notes: Nasal Swab. AE treatment Medication for neuropathy so far. Therapeutic measures were taken as a result of shock, pain in jaw, trigeminal neuralgia.  No follow-up attempts are needed. No further information is expected.
Intense Pain in my upper left arm and alot of weakness to raise arm lasting for 6 months, slowly going away.  Every now and then pain returns but quickly goes away.
Patient scheduled for Nurse visit that included Tb test and Covid booster. The vaccine was a prerequisite for a class.
Pt recvd measles vax & 15 to 20 min following vax pt devel stuffy nose, watery eyes & felt very uncomfortable; tx unspecified nasal spray; No further details were provided;
couple of blood clots in her lungs; she developed an A fib in the hospital; she had a problem with platelet production and was hospitalized. They gave her steroids and stuff to increase her platelet production; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 78-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Nov2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete but unknown manufacturer), for COVID-19 immunization. The following information was reported: PULMONARY THROMBOSIS (hospitalization, medically significant) with onset 2023, outcome "unknown", described as "couple of blood clots in her lungs"; ATRIAL FIBRILLATION (hospitalization, medically significant) with onset 2023, outcome "unknown", described as "she developed an A fib in the hospital"; PLATELET COUNT DECREASED (hospitalization) with onset 2023, outcome "unknown", described as "she had a problem with platelet production and was hospitalized. They gave her steroids and stuff to increase her platelet production". Caller mentioned that he is calling on behalf of his wife and wants to know if his wife can get another booster shot because she is on blood thinners. Caller stated: his wife is 78 years and he need to know if she should not get the shot. For the first 3 months of this year (2023), she had a problem with platelet production and was hospitalized. They gave her steroids and stuff to increase her platelet production, she's at home now, but still gets a weekly checkup to see where her platelet count is and an infusion to make sure it doesn't go too low. He addition that that she developed an A fib in the hospital so they decided to give her blood thinners, so can be imagined the mixture because she had a couple of blood clots in her lungs. She's home now but she is taking eliquis because of the A Fib and because of the clots. The caller's questions is, because of that history, should she not take the Pfizer Booster. Therapeutic measures were taken as a result of pulmonary thrombosis, atrial fibrillation, platelet count decreased.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt recv vax on 10/27/98; on same day pt exp red, itchy arm x 3 day
hardening of the area; pain and soreness in left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hardening of the area) and VACCINATION SITE PAIN (pain and soreness in left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029k20) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE INDURATION (hardening of the area) and VACCINATION SITE PAIN (pain and soreness in left arm). At the time of the report, VACCINATION SITE INDURATION (hardening of the area) and VACCINATION SITE PAIN (pain and soreness in left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.
Heart racing , 15 minutes after vaccine was administered, lasting for about 10-15 min. Itching  and rash  on  chest and upper back about an hour after vaccination.
Came down with Herpes Zoster  (Shingles) a little over a week after the 1st Pfizer shot.
heart attack on the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDIAL INFARCTION (medically significant) with onset 19Aug2022, outcome "unknown", described as "heart attack on the vaccine".  Clinical course: Patient stated that, he understand the ad but scared to take because he had a heart attack on the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Posterior leg bilateral pain (at knees) , sweats,  dizziness, sleepiness,  lethargic, was unable to go to work,  lobe, headache pain in center of head cramps to frontal , vision distortion, anxiety attack, body aches, pain/burning to to appendix area, right leg pain., constipation -loose burning diarrhea (4/13/21) reddish light brown in color, joint pain arm pain collar bone/shoulder, mucous, drink cool water pain to the chest-0wall noted, air bubbles  coming up in throat , upper neck, back spasms
Info has been received from an MD and a medical assistant concerning a 16 wk old male who on 4/18/01 at 5:00 was vax'd w/the first dose of Haemophilus B conjugate vax in the right leg. There was no illness at the time of vax and no concomitant medication. On that same date the PT developed an inject site reaction, irritability and somnolence. On 4/20/01, the PT recovered.
Fluvirin w/ Thimerosal given to OB pt. LMP = 2/10/2009. EDC = 11/17/2009. Pt does NOT have an OBGYN. Pt NOT hospitalized after receiving H1N1 vaccine.
This patient had redness and swelling on the right arm at the injection site on 01/30/01. On 01/31/01, his right arm was swollen, past 29 degrees at Trihibit site. Itching, but no fever. Swelling and patchy erythema on the right upper arm with excoriation.  Slight soft swelling at the Prevnar site, well perfused distally.
death U07.1, J12.82 - Pneumonia due to COVID-19 virus
I have pain around the elbow of my right arm after I took vaccination. It's been 26 days and I still have pain around the elbow of my right arm.
The patient did not experience any symptoms; a four month old infant was inadvertently administered one dose of GARDASIL 9; This spontaneous report was received from a physician referring to a 4-month-old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications.  On 30-DEC-2019, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (1 dose; dosage schedule, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis (product administered to patient of inappropriate age). It was reported that the patient did not experience any symptoms.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-1912USA012617:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 20Oct2022 as dose 5 (booster), single (Lot number: GH9703) at the age of 61 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Coronary Artery Disease" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "Hyperlipidemia" (unspecified if ongoing); "Overweight" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.
Subsequently post vax, the pt experienced arthralgias. An ER visit was required. The pt was treated with ibuprofen.
Headache, Myalgia, Fever, chills and sore arm  Narrative:   Other Relevant HIstory:
sore arm for 48 hours, headache for 48 hours and burning/hot eyes for48 hours
pt cried for 6hr;mom holding pt entire time & still unable to console;no fever or lethargy recalled;no vomiting;APAP given;
Developed very painful, stinging, burning, itching rash that spread from elbow to shoulder to wrist all up and down right arm (where Gardasil shot given).  Dx'd shingles.  No fever.
Patient got immunization about 9:49 A. 1/30/17. Had lunch and dinner. About 45 min. after dinner, was at funeral and sudden onset nausea and then vomited. Vomited numerous times during eve and night. Next AM felt nauseous, weak. Mother called to inform us.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Shakiness-Mild, Additional Details: patient has no medical condition and is not on medication. he had anxiety attack in the past. He passed out after covid administration and recovered a minute after. He did not have any other symptoms (i.e., shortness of breath, vomiting, swelling, vision changes, or so.) We gave him a 25 mg benadryl. We called 911 and his vital signs were normal when 911 checked. They admitted him to the hospital for monitoring the symptoms.
This patient complained of dizziness, weakness, and swelling of the pharynx. PE - WNL. No evidence of pharyngeal edema. Normal VS. The patient was monitored for 1 hour and patient is feeling better. The patient also observed to have intermittent left leg twitching. No previous history of seizure disorder.
Information has been received from a registered nurse concerning a 70 year old female homemaker with allergies to "statins", ezetimibe (MSD) and TRICOR, and a history of hypercholesterolaemia and hypothyroidism who on 22-JUN-2007 at 08:15, was vaccinated IM into the left deltoid with a first dose of PNEUMOVAX 23 (Lot # 656233/0200U).  Concomitant therapy included LEVOTHROID and OMEGA-3.  On 23-JUN-2007, the patient developed a rash that presented with warmth, very itchy, tenderness and pain and was macular in form.  It was reported that the rash started at the injection site and spread to the trunk, arm and face.  It was reported that the patient tried over the counter BENADRYL with no improvement.  On 26-JUN-2007 the patient was prescribed MEDROL.  On 02-JUL-2007, the physician saw the patient and prescribed prednisone 20 mg, one three dimes a day for 2 days, 1 by mouth twice a day for 3 days, half by mouth everyday for 3 days and ZYRTEC 10 mg.  No laboratory diagnostic studies were performed.  On approximately 06-JUL-2007, the patient recovered.  No product quality complaint was involved.  This is one of two reports from the same source.  Additional information is not expected.
my temperature is increasing and going; up to 103 degrees; I have got a 103 fever; body ache; I have got chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 62-year-old male patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 62 years for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing), notes: Asthma. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1 single, Unknown Manufacturer), for Covid-19 immunization; Covid-19 vaccine (Dose 2, single  Unknown Manufacturer), for Covid-19 immunization; Covid-19 vaccine (Dose 3(Booster), single Unknown Manufacturer), for Covid-19 immunization. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "my temperature is increasing and going; up to 103 degrees; I have got a 103 fever"; PAIN (non-serious), outcome "unknown", described as "body ache"; CHILLS (non-serious), outcome "unknown", described as "I have got chills". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, pain, chills. Additional information Reporter stated, I got my second COVID booster shot today, and my temperature is increasing and going up and now up to 103 degrees, the temperature, I have got body ache, I have got chills. Is there anything I can do for this. Other medical condition- he stated, Well I have Asthma, but this is not bothering my breathing. Other medication: patient stated, I have an inhaler. Name of Inhaler: patient stated, I think it is Albuterol, I am not able to get up and 'pull up' right now (Further clarification unknown hence not captured in tab).  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
tingling in the neck and side of face (cheek) that began around 20 minutes after vaccination.
Patient denied several times that he had received any previous covid 19 vaccines. Patient stated he was here for his first dose of Moderna Vaccine. After proper administratiwas mon of Moderna Vaccine, this writer proceeded to document administration of Moderna Vaccine into Immunization Information System. This writer became aware of administration of Johnson and Johnson Vaccine on 4/7/2021. This writer spoke with patient regarding previous Johnson and Johnson Vaccine. Patient stated " I know I already received the Johnson and Johnson Vaccine. I wanted the better vaccine. I was forced to take Johnson and  Johnson Vaccine to report to jury duty in person."  This writer and (Name) ( nurse site lead) discussed importance of disclosing all information honestly, clinical recommendations, instructions on not to receive second dose of Moderna , and to call 911/report to ER for any reactions. Patient verbalized understanding of all instructions.
I administered the MODERNA vaccine to patient. He directly went to sit in the waiting area. About 1 and 1/2 minutes later we were told by a customer that we had a patient in our waiting area laying on the floor. I immediately went out and saw him and told the staff to call 911. His body started convulsing and I repeated to call the manager and 911. I got down on the floor on his left side. He was face first in the concrete. There was a man sitting beside him with his hand on his back. He didn't look like he was breathing and I wanted to turn him on his back, but he started making sounds and I left him lay like he was. His body started convulsing again. Then store management appeared. The man started to lift his head and I could see that his nose looked cracked open and he was bleeding. He tried to get to a position on his knees and then I could see blood on the floor and coming from his mouth. I told him to continue to lay down and that the ambulance was coming. 2 fireman came over to assess the situation.  Then there was a woman there next to patient. It was his mother. She said that he has a history of fainting after shots. The man that was by patient's side on the floor was his father. EMS got there and started to take care of him. At this point he got to a sitting position against the wall. He did not remember any of what had happened. The EMS wanted to take him by ambulance to the hospital but patient was agitated and did not want to go by ambulance to the hospital. He thought he was fine but we were trying to tell him what had happened to him. He got up and went to the front with the EMS to sign a form. His mother and father wanted him to go to hospital to get checked out because he has never had a seizure before. We have not heard anything back yet.
Flu like symptoms: body aches, fever, chills, shivering, headache, general malaise